It is good to see that the fence that SUD is building around Anagrelide is getting bigger. The markets are attractive so if the clinical studies unfold well it should create a nice upswing in valuation. That's a little way off but I think we can the plan unfolding. GLTA
Ann: Anagrelide Cancer Patent For Australia, page-4
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.005(3.57%) |
Mkt cap ! $152.5M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 14.5¢ | 14.0¢ | $47.52K | 327.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7168 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 374430 | 9 |
View Market Depth
| Last trade - 15.39pm 23/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |